BlackRock’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.9M | Buy |
3,097,760
+647,733
| +26% | +$8.76M | ﹤0.01% | 2522 |
|
|
2025
Q1 | $38.9M | Buy |
2,450,027
+311,505
| +15% | +$4.95M | ﹤0.01% | 2489 |
|
|
2024
Q4 | $26.3M | Sell |
2,138,522
-5,646
| -0.3% | -$69.5K | ﹤0.01% | 2828 |
|
|
2024
Q3 | $26M | Buy |
2,144,168
+98,466
| +5% | +$1.19M | ﹤0.01% | 2828 |
|
|
2024
Q2 | $23.9M | Buy |
2,045,702
+702,139
| +52% | +$8.22M | ﹤0.01% | 2825 |
|
|
2024
Q1 | $17.3M | Sell |
1,343,563
-51,211
| -4% | -$661K | ﹤0.01% | 3014 |
|
|
2023
Q4 | $12M | Buy |
1,394,774
+499,725
| +56% | +$4.3M | ﹤0.01% | 3231 |
|
|
2023
Q3 | $8.51M | Buy |
895,049
+10,789
| +1% | +$103K | ﹤0.01% | 3379 |
|
|
2023
Q2 | $15.1M | Buy |
884,260
+134,571
| +18% | +$2.29M | ﹤0.01% | 3135 |
|
|
2023
Q1 | $11.7M | Buy |
+749,689
| New | +$11.7M | ﹤0.01% | 3165 |
|